(iii) Expanding beyond MLH1 and MSH2 genes would enhance generalizability across diverse genetic backgrounds, e.g., confirmed PV in the MSH6 and PMS2 genes, would expand our understanding of cancer manifestation variability across all relevant MMR genes. This evidence concerns the gene PMS2 and cancer.